Jahn Nesland

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Genes & Molecular Sequences

p53 Genes

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Konstantinovsky Sophya; Smith Yoav; Zilber Sofia; Tuft Stavnes Helene; Becker Anne-Marie; Nesland Jahn M; Reich Reuven; Davidson Ben
Breast carcinoma cells in primary tumors and effusions have different gene array profiles.
Lü Xinquan; Li Huixiang; Xu Kejia; Nesland Jahn M; Suo Zhenhe
MUC-1-/ESA+ progenitor cells in normal, benign and malignant human breast epithelial cells.
Yuan Yuan; Nymoen Dag André; Stavnes Helene Tuft; Rosnes Anne Katrine; Bjørang Ola; Wu Chuanyue; Nesland Jahn M; Davidson Ben
Tenascin-X is a novel diagnostic marker of malignant mesothelioma.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Jahn Nesland (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2010: Konstantinovsky Sophya; Smith Yoav; Zilber Sofia; Tuft Stavnes Helene; Becker Anne-Marie; Nesland Jahn M; Reich Reuven; Davidson Ben
Breast carcinoma cells in primary tumors and effusions have different gene array profiles.
Journal of oncology 2010;2010():969084.
2009: Lü Xinquan; Li Huixiang; Xu Kejia; Nesland Jahn M; Suo Zhenhe
MUC-1-/ESA+ progenitor cells in normal, benign and malignant human breast epithelial cells.
Histology and histopathology 2009;24(11):1381-90.
2009: Yuan Yuan; Nymoen Dag André; Stavnes Helene Tuft; Rosnes Anne Katrine; Bjørang Ola; Wu Chuanyue; Nesland Jahn M; Davidson Ben
Tenascin-X is a novel diagnostic marker of malignant mesothelioma.
The American journal of surgical pathology 2009;33(11):1673-82.
2009: Dhakal Hari Prasad; Bassarova Assia; Naume Bjørn; Synnestvedt Marit; Borgen Elin; Kaaresen Rolf; Schlichting Ellen; Wiedswang Gro; Giercksky Karl-Erik; Nesland Jahn M
Breast carcinoma vascularity: a comparison of manual microvessel count and Chalkley count.
Histology and histopathology 2009;24(8):1049-59.
2009: Holm Ruth; Ali Tayeba; Svendsrud Debbie H; Nesland Jahn M; Kristensen Gunnar B; Lyng Heidi
Expression of 14-3-3sigma in cervical squamous cell carcinomas: relationship with clinical outcome.
Oncology reports 2009;22(1):11-5.
2009: Kleinberg Lilach; Dong Hiep Phuc; Holth Arild; Risberg Björn; Trope' Claes G; Nesland Jahn M; Flørenes Vivi Ann; Davidson Ben
Cleaved caspase-3 and nuclear factor-kappaB p65 are prognostic factors in metastatic serous ovarian carcinoma.
Human pathology 2009;40(6):795-806.
2009: Wang Qi; He Wei; Lu Changdong; Wang Zhong; Wang Junsheng; Giercksky Karl Erik; Nesland Jahn M; Suo Zhenhe
Oct3/4 and Sox2 are significantly associated with an unfavorable clinical outcome in human esophageal squamous cell carcinoma.
Anticancer research 2009;29(4):1233-41.
2009: Knopp S; Tropè C; Nesland J M; Holm R
A review of molecular pathological markers in vulvar carcinoma: lack of application in clinical practice.
Journal of clinical pathology 2009;62(3):212-8.
2009: Abeler Vera M; Røyne Odd; Thoresen Steinar; Danielsen Håvard E; Nesland Jahn M; Kristensen Gunnar B
Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients.
Histopathology 2009;54(3):355-64.
2008: Berg Arne; Bruland Øyvind S; Fosså Sophie D; Nesland Jahn M; Berner Aasmund; Schirmer Cecilie; Lilleby Wolfgang
Disseminated tumor cells in bone marrow following definitive radiotherapy for intermediate or high-risk prostate cancer.
The Prostate 2008;68(15):1607-14.
2008: Kleinberg Lilach; Pradhan Manohar; Tropé Claes G; Nesland Jahn M; Davidson Ben; Risberg Björn
Ovarian carcinoma cells in effusions show increased S-phase fraction compared to corresponding primary tumors.
Diagnostic cytopathology 2008;36(9):637-44.
2008: Knopp Synne; Nesland Jahn M; Tropé Claes
SLNB and the importance of micrometastases in vulvar squamous cell carcinoma.
Surgical oncology 2008;17(3):219-25.
2008: Dhakal Hari Prasad; Naume Bjørn; Synnestvedt Marit; Borgen Elin; Kaaresen Rolf; Schlichting Ellen; Wiedswang Gro; Bassarova Assia; Giercksky Karl-Erik; Nesland Jahn M
Vascularization in primary breast carcinomas: its prognostic significance and relationship with tumor cell dissemination.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(8):2341-50.
2008: Bergamaschi A; Tagliabue E; Sørlie T; Naume B; Triulzi T; Orlandi R; Russnes H G; Nesland J M; Tammi R; Auvinen P; Kosma V-M; Ménard S; Børresen-Dale A-L
Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome.
The Journal of pathology 2008;214(3):357-67.
2008: Dong Hiep Phuc; Kleinberg Lilach; Silins Ilvars; Flørenes Vivi Ann; Tropé Claes G; Risberg Björn; Nesland Jahn M; Davidson Ben
Death receptor expression is associated with poor response to chemotherapy and shorter survival in metastatic ovarian carcinoma.
Cancer 2008;112(1):84-93.
2008: Holm R; Knopp S; Kumar R; Lee J; Nesland J M; Tropè C; Callen D F
Expression of ZNF652, a novel zinc finger protein, in vulvar carcinomas and its relation to prognosis.
Journal of clinical pathology 2008;61(1):59-63.
2008: Wang Zhihui; Tropè Claes G; Suo Zhenhe; Trøen Gunhild; Yang Guanrui; Nesland Jahn M; Holm Ruth
The clinicopathological and prognostic impact of 14-3-3 sigma expression on vulvar squamous cell carcinomas.
BMC cancer 2008;8():308.
2008: Bjerkehagen Bodil; Smeland Sigbjørn; Walberg Lise; Skjeldal Sigmund; Hall Kirsten Sundby; Nesland Jahn M; Småstuen Milada Cvancarova; Fosså Sophie D; Saeter Gunnar
Radiation-induced sarcoma: 25-year experience from the Norwegian Radium Hospital.
Acta oncologica (Stockholm, Sweden) 2008;47(8):1475-82.
2007: Bartkova J; Horejsí Z; Sehested M; Nesland J M; Rajpert-De Meyts E; Skakkebaek N E; Stucki M; Jackson S; Lukas J; Bartek J
DNA damage response mediators MDC1 and 53BP1: constitutive activation and aberrant loss in breast and lung cancer, but not in testicular germ cell tumours.
Oncogene 2007;26(53):7414-22.
2007: Wu Qinghua; Lind Guro E; Aasheim Hans-Christian; Micci Francesca; Silins Ilvars; Tropé Claes G; Nesland Jahn M; Lothe Ragnhild A; Suo Zhenhe
The EPH receptor Bs (EPHBs) promoters are unmethylated in colon and ovarian cancers.
Epigenetics : official journal of the DNA Methylation Society 2007;2(4):237-43.
2007: Khouja M Haysam; Baekelandt Mark; Nesland Jahn M; Holm Ruth
The clinical importance of Ki-67, p16, p14, and p57 expression in patients with advanced ovarian carcinoma.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2007;26(4):418-25.
2007: Holm R; Knopp S; Suo Z; Tropè C; Nesland J M
Expression of EphA2 and EphrinA-1 in vulvar carcinomas and its relation to prognosis.
Journal of clinical pathology 2007;60(10):1086-91.
2007: Naume Bjørn; Zhao Xi; Synnestvedt Marit; Borgen Elin; Russnes Hege Giercksky; Lingjaerde Ole Christian; Strømberg Maria; Wiedswang Gro; Kvalheim Gunnar; Kåresen Rolf; Nesland Jahn M; Børresen-Dale Anne-Lise; Sørlie Therese
Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer.
Molecular oncology 2007;1(2):160-71.
2007: Kleinberg Lilach; Flørenes Vivi Ann; Nesland Jahn M; Davidson Ben
Survivin, a member of the inhibitors of apoptosis family, is down-regulated in breast carcinoma effusions.
American journal of clinical pathology 2007;128(3):389-97.
2007: Kleinberg Lilach; Lie Agnes Kathrine; Flørenes Vivi Ann; Nesland Jahn M; Davidson Ben
Expression of inhibitor-of-apoptosis protein family members in malignant mesothelioma.
Human pathology 2007;38(7):986-94.
2007: Zhang Meng-Zhen; Qiao Yu-Huan; Nesland Jahn M; Trope Claes; Kennedy Alanna; Chen Wen Tien; Suo Zhen-He
Expression of seprase in effusions from patients with epithelial ovarian carcinoma.
Chinese medical journal 2007;120(8):663-8.
2007: Cunderlíková B; Wahlqvist R; Berner A; Vasovic V; Warloe T; Nesland J M; Peng Q
Detection of urinary bladder cancer with flow cytometry and hexaminolevulinate in urine samples.
Cytopathology : official journal of the British Society for Clinical Cytology 2007;18(2):87-95.
2007: Berg Arne; Berner Aasmund; Lilleby Wolfgang; Bruland Øyvind S; Fosså Sophie D; Nesland Jahn M; Kvalheim Gunnar
Impact of disseminated tumor cells in bone marrow at diagnosis in patients with nonmetastatic prostate cancer treated by definitive radiotherapy.
International journal of cancer. Journal international du cancer 2007;120(8):1603-9.
2007: Kleinberg Lilach; Flørenes Vivi Ann; Silins Ilvars; Haug Kristiane; Trope Claes G; Nesland Jahn M; Davidson Ben
Nuclear expression of survivin is associated with improved survival in metastatic ovarian carcinoma.
Cancer 2007;109(2):228-38.
2007: Wu Qinghua; Lothe Ragnhild A; Ahlquist Terje; Silins Ilvars; Tropé Claes G; Micci Francesca; Nesland Jahn M; Suo Zhenhe; Lind Guro E
DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets.
Molecular cancer 2007;6():45.
2007: Langerød Anita; Zhao Hongjuan; Borgan Ørnulf; Nesland Jahn M; Bukholm Ida R K; Ikdahl Tone; Kåresen Rolf; Børresen-Dale Anne-Lise; Jeffrey Stefanie S
TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer.
Breast cancer research : BCR 2007;9(3):R30.
2007: Kleivi Kristine; Lind Guro E; Diep Chieu B; Meling Gunn I; Brandal Lin T; Nesland Jahn M; Myklebost Ola; Rognum Torleiv O; Giercksky Karl-Erik; Skotheim Rolf I; Lothe Ragnhild A
Gene expression profiles of primary colorectal carcinomas, liver metastases, and carcinomatoses.
Molecular cancer 2007;6():2.
2006: Steffensen Inger-Lise; Schut Herman A J; Nesland Jahn M; Tanaka Kiyoji; Alexander Jan
Role of nucleotide excision repair deficiency in intestinal tumorigenesis in multiple intestinal neoplasia (Min) mice.
Mutation research 2006;611(1-2):71-82.
2006: Ji Zhenyu; Yang Guanrui; Shahzidi Susan; Tkacz-Stachowska Kinga; Suo Zhenhe; Nesland Jahn M; Peng Qian
Induction of hypoxia-inducible factor-1alpha overexpression by cobalt chloride enhances cellular resistance to photodynamic therapy.
Cancer letters 2006;244(2):182-9.
2006: Furre Ingegerd Eggen; Møller Michael T N; Shahzidi Susan; Nesland Jahn M; Peng Qian
Involvement of both caspase-dependent and -independent pathways in apoptotic induction by hexaminolevulinate-mediated photodynamic therapy in human lymphoma cells.
Apoptosis : an international journal on programmed cell death 2006;11(11):2031-42.
2006: Borgen E; Pantel K; Schlimok G; Müller P; Otte M; Renolen A; Ehnle S; Coith C; Nesland J M; Naume B
A European interlaboratory testing of three well-known procedures for immunocytochemical detection of epithelial cells in bone marrow. Results from analysis of normal bone marrow.
Cytometry. Part B, Clinical cytometry 2006;70(6):400-9.
2006: Chen Donghai; Kennedy Alanna; Wang Jaw-Yuan; Zeng Wei; Zhao Qiang; Pearl Michael; Zhang Mengzhen; Suo Zhenhe; Nesland Jahn M; Qiao Yuhuan; Ng Ah-Kau; Hirashima Naoko; Yamane Tetsu; Mori Yoshiyuki; Mitsumata Masako; Ghersi Giulio; Chen Wen-Tien
Activation of EDTA-resistant gelatinases in malignant human tumors.
Cancer research 2006;66(20):9977-85.
2006: Bukholm Ida R K; Nesland Jahn M; Bukholm Geir
Expression of adhesion proteins E-cadherin, alpha-catenin, beta-catenin and gamma-catenin is different in T1 and T2 breast tumours.
Pathology 2006;38(5):403-7.
2006: Knopp S; Holm R; Bjørge T; Tropé C; Nesland J M
Cell cycle regulation in primary vulvar carcinomas and related lymph node metastases.
Histopathology 2006;49(3):311-2.
2006: Ji Zhenyu; Yang Guanrui; Vasovic Vlada; Cunderlikova Beata; Suo Zhenhe; Nesland Jahn M; Peng Qian
Subcellular localization pattern of protoporphyrin IX is an important determinant for its photodynamic efficiency of human carcinoma and normal cell lines.
Journal of photochemistry and photobiology. B, Biology 2006;84(3):213-20.
2006: Davidson Ben; Konstantinovsky Sophya; Kleinberg Lilach; Nguyen Mai T P; Bassarova Assia; Kvalheim Gunnar; Nesland Jahn M; Reich Reuven
The mitogen-activated protein kinases (MAPK) p38 and JNK are markers of tumor progression in breast carcinoma.
Gynecologic oncology 2006;102(3):453-61.
2006: Knopp Synne; Nesland Jahn M; Tropé Claes; Holm Ruth
p14ARF, a prognostic predictor in HPV-negative vulvar carcinoma.
American journal of clinical pathology 2006;126(2):266-76.
2006: Helland Aslaug; Johnsen Hilde; Frøyland Caroline; Landmark Hege B K; Saetersdal Anna B; Holmen Marit Muri; Gjertsen Turid; Nesland Jahn M; Ottestad William; Jeffrey Stefanie S; Ottestad Lars O; Rodningen Olag K; Sherlock Gavin; Børresen-Dale Anne-Lise
Radiation-induced effects on gene expression: an in vivo study on breast cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2006;80(2):230-5.
2006: Reis-Filho J S; Milanezi F; Steele D; Savage K; Simpson P T; Nesland J M; Pereira E M; Lakhani S R; Schmitt F C
Metaplastic breast carcinomas are basal-like tumours.
Histopathology 2006;49(1):10-21.
2006: Bassarova Assia V; Nesland Jahn M; Davidson Ben
D2-40 is not a specific marker for cells of mesothelial origin in serous effusions.
The American journal of surgical pathology 2006;30(7):878-82.
2006: Amarzguioui Mohammed; Peng Qian; Wiiger Merete T; Vasovic Vlada; Babaie Eshrat; Holen Torgeir; Nesland Jahn M; Prydz Hans
Ex vivo and in vivo delivery of anti-tissue factor short interfering RNA inhibits mouse pulmonary metastasis of B16 melanoma cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(13):4055-61.
2006: Kleinberg Lilach; Flørenes Vivi Ann; Skrede Martina; Dong Hiep Phuc; Nielsen Søren; McMaster Michael T; Nesland Jahn M; Shih Ie-Ming; Davidson Ben
Expression of HLA-G in malignant mesothelioma and clinically aggressive breast carcinoma.
Virchows Archiv : an international journal of pathology 2006;449(1):31-9.
2006: Wu Qinghua; Suo Zhenhe; Kristensen Gunnar B; Baekelandt Mark; Nesland Jahn M
The prognostic impact of EphB2/B4 expression on patients with advanced ovarian carcinoma.
Gynecologic oncology 2006;102(1):15-21.
2006: Drageset Vilde; Nesland Jahn M; Erikstein Bjorn; Skovlund Eva; Sommer Hilde; Anker Gun; Wist Erik; Lundgren Steinar; Bergh Jonas; Kvalheim Gunnar
Monitoring of disseminated tumor cells in bone marrow in high-risk breast cancer patients treated with high-dose chemotherapy.
International journal of cancer. Journal international du cancer 2006;118(11):2877-81.
2006: Aghmesheh Morteza; Suo Zhenhe; Friedlander Michael; Nesland Jahn M; Kaern Janne; Stewart Michael; Kconfab; Dorum Anne; Tucker Katherine M; Buckley Michael F
Chromosome 2q24.2 is lost in sporadic but not in BRCA1-associated ovarian carcinomas.
Pathology 2006;38(2):145-51.
2006: Wiedswang Gro; Borgen Elin; Schirmer Cecilie; Kåresen Rolf; Kvalheim Gunnar; Nesland Jahn M; Naume Bjørn
Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer.
International journal of cancer. Journal international du cancer 2006;118(8):2013-9.
2006: Bondi Johan; Bukholm Geir; Nesland Jahn M; Bakka Arne; Bukholm Ida R K
An increase in the number of adhesion proteins with altered expression is associated with an increased risk of cancer death for colon carcinoma patients.
International journal of colorectal disease 2006;21(3):231-7.
2006: Shahzidi Susan; Stokke Trond; Soltani Hela; Nesland Jahn M; Peng Qian
Induction of apoptosis by hexaminolevulinate-mediated photodynamic therapy in human colon carcinoma cell line 320DM.
Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer 2006;25(1-2):159-71.
2006: Godal Aslak; Nilsen Nils O; Klaveness Jo; Branden Jon Erik; Nesland Jahn M; Peng Qian
New derivatives of 5-aminolevulinic acid for photodynamic therapy: chemical synthesis and porphyrin production in in vitro and in vivo biological systems.
Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer 2006;25(1-2):109-26.
2005: Furre Ingegerd Eggen; Shahzidi Susan; Luksiene Zivile; Møller Michael T N; Borgen Elin; Morgan Janet; Tkacz-Stachowska Kinga; Nesland Jahn M; Peng Qian
Targeting PBR by hexaminolevulinate-mediated photodynamic therapy induces apoptosis through translocation of apoptosis-inducing factor in human leukemia cells.
Cancer research 2005;65(23):11051-60.
2005: Kringen Pedro; Bergamaschi Anna; Due Eldri Undlien; Wang Yun; Tagliabue Elda; Nesland Jahn M; Nehman Aune; Tönisson Neeme; Børresen-Dale Anne-Lise
Evaluation of arrayed primer extension for TP53 mutation detection in breast and ovarian carcinomas.
BioTechniques 2005;39(5):755-61.
2005: Konstantinovsky Sophya; Nielsen Søren; Vyberg Mogens; Kvalheim Gunnar; Nesland Jahn M; Reich Reuven; Davidson Ben
Angiogenic molecule expression is downregulated in effusions from breast cancer patients.
Breast cancer research and treatment 2005;94(1):71-80.
2005: Han Liping; Dong Ziming; Qiao Yuhuan; Kristensen Gunnar B; Holm Ruth; Nesland Jahn M; Suo Zhenhe
The clinical significance of EphA2 and Ephrin A-1 in epithelial ovarian carcinomas.
Gynecologic oncology 2005;99(2):278-86.
2005: Knopp Synne; Holm Ruth; Tropé Claes; Nesland Jahn M
Occult lymph node metastases in early stage vulvar carcinoma patients.
Gynecologic oncology 2005;99(2):383-7.
2005: Wang Yun; Kristensen Gunnar B; Helland Aslaug; Nesland Jahn M; Børresen-Dale Anne-Lise; Holm Ruth
Protein expression and prognostic value of genes in the erb-b signaling pathway in advanced ovarian carcinomas.
American journal of clinical pathology 2005;124(3):392-401.
2005: Bassarova Assia V; Nesland Jahn M; Sedloev Theophil; Lilleby Wolfgang; Hristova Svetlana L; Trifonov Dimitar Y; Torlakovic Emina
Simultaneous bilateral breast carcinomas: a category with frequent coexpression of HER-2 and ER-alpha, high Ki-67 and bcl-2, and low p53.
International journal of surgical pathology 2005;13(3):239-46.
2005: Xu Feng; Zhong Wang; Li Jichang; Shanshen Zhang; Cui Jianguo; Nesland Jahn M; Suo Zhenhe
Predictive value of EphA2 and EphrinA-1 expression in oesophageal squamous cell carcinoma.
Anticancer research 2005;25(4):2943-50.
2005: Skotheim Rolf I; Lind Guro E; Monni Outi; Nesland Jahn M; Abeler Vera M; Fosså Sophie D; Duale Nur; Brunborg Gunnar; Kallioniemi Olli; Andrews Peter W; Lothe Ragnhild A
Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development.
Cancer research 2005;65(13):5588-98.
2005: Bassarova A V; Torlakovic E; Sedloev T; Hristova S L; Trifonov D V; Nesland J M
Simultaneous bilateral breast carcinoma: Histopathological characteristics and CD44/catenin-cadherin profile.
Histology and histopathology 2005;20(3):791-9.
2005: Torlakovic Emina; Malecka Agnieszka; Myklebust June H; Tierens Anne; Aasheim Hans-Christian; Nesland Jahn M; Smeland Erlend; Kvaløy Stein; Delabie Jan
PU.1 protein expression has a positive linear association with protein expression of germinal centre B cell genes including BCL-6, CD10, CD20 and CD22: identification of PU.1 putative binding sites in the BCL-6 promotor.
The Journal of pathology 2005;206(3):312-9.
2005: Knopp Synne; Bjørge Tone; Nesland Jahn M; Tropé Claes; Holm Ruth
Cyclins D1, D3, E, and A in vulvar carcinoma patients.
Gynecologic oncology 2005;97(3):733-9.
2005: Torlakovic Goran; Torlakovic Emina; Skovlund Eva; Nesland Jahn M; Reith Albrecht; Danielsen Havard E
Volume-related sequence of tumor distribution pattern in prostate carcinoma: importance of posterior midline crossover in predicting tumor volume, extracapsular extension, and seminal vesicle invasion.
Croatian medical journal 2005;46(3):429-35.
2005: Kildal Wanja; Risberg Björn; Abeler Vera M; Kristensen Gunnar B; Sudbø Jon; Nesland Jahn M; Danielsen Håvard E
beta-catenin expression, DNA ploidy and clinicopathological features in ovarian cancer: a study in 253 patients.
European journal of cancer (Oxford, England : 1990) 2005;41(8):1127-34.
2005: Bondi J; Husdal A; Bukholm G; Nesland J M; Bakka A; Bukholm I R K
Expression and gene amplification of primary (A, B1, D1, D3, and E) and secondary (C and H) cyclins in colon adenocarcinomas and correlation with patient outcome.
Journal of clinical pathology 2005;58(5):509-14.
2005: Bartkova Jirina; Horejsí Zuzana; Koed Karen; Krämer Alwin; Tort Frederic; Zieger Karsten; Guldberg Per; Sehested Maxwell; Nesland Jahn M; Lukas Claudia; Ørntoft Torben; Lukas Jiri; Bartek Jiri
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.
Nature 2005;434(7035):864-70.
2005: Elloul Sivan; Elstrand Mari Bukholt; Nesland Jahn M; Tropé Claes G; Kvalheim Gunnar; Goldberg Iris; Reich Reuven; Davidson Ben
Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma.
Cancer 2005;103(8):1631-43.
2005: Shi Hui-Rong; Wu Qing-Hua; Suo Zhen-He; Nesland Jahn M
[Correlation between methylation of 5'-CpG islands and inactivation of FHIT gene in cervical cancer.]
Ai zheng = Aizheng = Chinese journal of cancer 2005;24(1):7-11.
2005: Reis-Filho Jorge S; Milanezi Fernanda; Carvalho Silvia; Simpson Pete T; Steele Dawn; Savage Kay; Lambros Maryou B K; Pereira Emilio M; Nesland Jahn M; Lakhani Sunil R; Schmitt Fernando C
Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis.
Breast cancer research : BCR 2005;7(6):R1028-35.
2005: Kringen Pedro; Wang Yun; Dumeaux Vanessa; Nesland Jahn M; Kristensen Gunnar; Borresen-Dale Anne-Lise; Dorum Anne
TP53 mutations in ovarian carcinomas from sporadic cases and carriers of two distinct BRCA1 founder mutations; relation to age at diagnosis and survival.
BMC cancer 2005;5():134.
2005: Schaner Marci E; Davidson Ben; Skrede Martina; Reich Reuven; Flørenes Vivi Ann; Risberg Björn; Berner Aasmund; Goldberg Iris; Givant-Horwitz Vered; Tropè Claes G; Kristensen Gunnar B; Nesland Jahn M; Børresen-Dale Anne-Lise
Variation in gene expression patterns in effusions and primary tumors from serous ovarian cancer patients.
Molecular cancer 2005;4():26.
2004: Aghmesheh Morteza; Nesland Jahn M; Kaern Janne; Dorum Anne; Edwards Lyndal; Byth Karen; Friedlander Michael; Jackson Paul; Tucker Katherine M; Russell Pamela J
No differences in p53 mutation frequencies between BRCA1-associated and sporadic ovarian cancers.
Gynecologic oncology 2004;95(3):430-6.
2004: Li Hui-xiang; Zh Suo; Zhang Yun-han; Risberg Bjørn; Karlsson Mats G; Nesland Jahn M
[Expressions of thymidine phosphorylase, thymidylate synthase and dihydropyrimidine dehydrogenase in breast cancer and their correlations with prognosis.]
Zhonghua zhong liu za zhi [Chinese journal of oncology] 2004;26(11):669-72.
2004: Torlakovic Emina E; Bilalovic Nurija; Nesland Jahn M; Torlakovic Goran; Flørenes Vivi A
Ets-1 transcription factor is widely expressed in benign and malignant melanocytes and its expression has no significant association with prognosis.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2004;17(11):1400-6.
2004: Suo Zhenhe; Daehli Kathinka U; Lindboe Christian Fr; Borgen Elin; Bassarova Assia; Nesland Jahn M
Real-time PCR quantification of c-erbB-2 gene is an alternative for FISH in the clinical management of breast carcinoma patients.
International journal of surgical pathology 2004;12(4):311-8.
2004: Knopp Synne; Bjørge Tone; Nesland Jahn M; Tropé Claes; Scheistrøen Marit; Holm Ruth
p16INK4a and p21Waf1/Cip1 expression correlates with clinical outcome in vulvar carcinomas.
Gynecologic oncology 2004;95(1):37-45.
2004: Bilalovic Nurija; Sandstad Berit; Golouh Rastko; Nesland Jahn M; Selak Ivan; Torlakovic Emina E
CD10 protein expression in tumor and stromal cells of malignant melanoma is associated with tumor progression.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2004;17(10):1251-8.
2004: Peng Qian; Nesland Jahn M
Effects of photodynamic therapy on tumor stroma.
Ultrastructural pathology 2004;28(5-6):333-40.
2004: Wiedswang Gro; Borgen Elin; Kåresen Rolf; Qvist Hanne; Janbu Jan; Kvalheim Gunnar; Nesland Jahn M; Naume Bjørn
Isolated tumor cells in bone marrow three years after diagnosis in disease-free breast cancer patients predict unfavorable clinical outcome.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(16):5342-8.
2004: Wu Dan; Suo Zhenhe; Kristensen Gunnar B; Li Shanshan; Troen Gunhild; Holm Ruth; Nesland Jahn M
Prognostic value of EphA2 and EphrinA-1 in squamous cell cervical carcinoma.
Gynecologic oncology 2004;94(2):312-9.
2004: Andersen Kristin; Nesland Jahn M; Holm Ruth; Flørenes Vivi A; Fodstad Øystein; Maelandsmo Gunhild M
Expression of S100A4 combined with reduced E-cadherin expression predicts patient outcome in malignant melanoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2004;17(8):990-7.
2004: Davidson Ben; Suo Zhenhe; Nesland Jahn M
Malignant mesothelioma.
Ultrastructural pathology 2004;28(4):179-80.
2004: Wang Yun; Kringen Pedro; Kristensen Gunnar B; Holm Ruth; Baekelandt Mark M O; Olivier Magali; Skomedal Hanne; Hainaut Pierre; Tropé Claes G; Abeler Vera M; Nesland Jahn M; Børresen-Dale Anne-Lise; Helland Aslaug
Effect of the codon 72 polymorphism (c.215G>C, p.Arg72Pro) in combination with somatic sequence variants in the TP53 gene on survival in patients with advanced ovarian carcinoma.
Human mutation 2004;24(1):21-34.
2004: Flørenes Vivi Ann; Skrede Martina; Jørgensen Kjersti; Nesland Jahn M
Deacetylase inhibition in malignant melanomas: impact on cell cycle regulation and survival.
Melanoma research 2004;14(3):173-81.
2004: Zhao Hongjuan; Langerød Anita; Ji Youngran; Nowels Kent W; Nesland Jahn M; Tibshirani Rob; Bukholm Ida K; Kåresen Rolf; Botstein David; Børresen-Dale Anne-Lise; Jeffrey Stefanie S
Different gene expression patterns in invasive lobular and ductal carcinomas of the breast.
Molecular biology of the cell 2004;15(6):2523-36.
2004: Suo Zhenhe; Karbovo Eleonora; Trope Claes G; Metodiev Krassimir; Nesland Jahn M
Papillary serous carcinoma of the ovary: an ultrastructural and immunohistochemical study.
Ultrastructural pathology 2004;28(3):141-7.
2004: Nesland Jahn M
Chronic cholecystitis.
Ultrastructural pathology 2004;28(3):121.
2004: Naume Bjørn; Wiedswang Gro; Borgen Elin; Kvalheim Gunnar; Kåresen Rolf; Qvist Hanne; Janbu Jan; Harbitz Torstein; Nesland Jahn M
The prognostic value of isolated tumor cells in bone marrow in breast cancer patients: evaluation of morphological categories and the number of clinically significant cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(9):3091-7.
2004: Reed Wenche; Bøhler Per J; Sandstad Berit; Nesland Jahn M
Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up.
The breast journal 2004;10(3):174-80.
2004: Givant-Horwitz Vered; Davidson Ben; Goderstad Jeanne Mette; Nesland Jahn M; Tropé Claes G; Reich Reuven
The PAC-1 dual specificity phosphatase predicts poor outcome in serous ovarian carcinoma.
Gynecologic oncology 2004;93(2):517-23.
2004: Bassarova Assia; Nesland Jahn M; Sedloev Theophil; Danielsen Håvard; Christova Svetlana
Pilomatrix carcinoma with lymph node metastases.
Journal of cutaneous pathology 2004;31(4):330-5.
2004: Nesland Jahn M
Ultrastructural and molecular analysis of cribriform-morular variant of papillary thyroid carcinoma.
Ultrastructural pathology 2004;28(2):53.
2004: Diep Chieu B; Teixeira Manuel R; Thorstensen Lin; Wiig Johan N; Eknaes Mette; Nesland Jahn M; Giercksky Karl-Erik; Johansson Bertil; Lothe Ragnhild A
Genome characteristics of primary carcinomas, local recurrences, carcinomatoses, and liver metastases from colorectal cancer patients.
Molecular cancer 2004;3():6.
2004: Davidson Ben; Reich Reuven; Lazarovici Philip; Ann Flørenes Vivi; Nielsen Søren; Nesland Jahn M
Altered expression and activation of the nerve growth factor receptors TrkA and p75 provide the first evidence of tumor progression to effusion in breast carcinoma.
Breast cancer research and treatment 2004;83(2):119-28.
2004: Nesland Jahn M
Ultrastructural examination and technical developments.
Ultrastructural pathology 2004;28(1):1.
2004: Bondi Johan; Bukholm Geir; Nesland Jahn M; Bukholm Isa R K
Expression of non-membranous beta-catenin and gamma-catenin, c-Myc and cyclin D1 in relation to patient outcome in human colon adenocarcinomas.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2004;112(1):49-56.
2004: Bilalovic Nurija; Blystad Anne Kirsti; Golouh Rastko; Nesland Jahn M; Selak Ivan; Trinh Don; Torlakovic Emina
Expression of bcl-6 and CD10 protein is associated with longer overall survival and time to treatment failure in follicular lymphoma.
American journal of clinical pathology 2004;121(1):34-42.
2004: Hernes E; Fosså S D; Berner Aa; Otnes B; Nesland J M
Expression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independence.
British journal of cancer 2004;90(2):449-54.
2004: Li H; Suo Z; Zhang Y; Risberg B; Karlsson M G; Villman K; Nesland J M
The prognostic significance of thymidine phosphorylase, thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expressions in breast carcinomas.
Histology and histopathology 2004;19(1):129-36.
2004: Wu Dan; Qiao Yuhuan; Kristensen Gunnar B; Li Shanshan; Troen Gunhild; Holm Ruth; Nesland Jahn M; Suo Zhenhe
Prognostic significance of dysadherin expression in cervical squamous cell carcinoma.
Pathology oncology research : POR 2004;10(4):212-8.
2004: Naume B; Borgen E; Tøssvik S; Pavlak N; Oates D; Nesland J M
Detection of isolated tumor cells in peripheral blood and in BM: evaluation of a new enrichment method.
Cytotherapy 2004;6(3):244-52.
2004: Wu Qinghua; Suo Zhenhe; Risberg Bjørn; Karlsson Mats G; Villman Kenneth; Nesland Jahn M
Expression of Ephb2 and Ephb4 in breast carcinoma.
Pathology oncology research : POR 2004;10(1):26-33.
2003: Skotheim Rolf I; Kallioniemi Anne; Bjerkhagen Bodil; Mertens Fredrik; Brekke Helge R; Monni Outi; Mousses Spyro; Mandahl Nils; Soeter Gunnar; Nesland Jahn M; Smeland Sigbjørn; Kallioniemi Olli-P; Lothe Ragnhild A
Topoisomerase-II alpha is upregulated in malignant peripheral nerve sheath tumors and associated with clinical outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(24):4586-91.
2003: Skotheim Rolf I; Korkmaz Kemal S; Klokk Tove I; Abeler Vera M; Korkmaz Ceren G; Nesland Jahn M; Fosså Sophie D; Lothe Ragnhild A; Saatcioglu Fahri
NKX3.1 expression is lost in testicular germ cell tumors.
The American journal of pathology 2003;163(6):2149-54.
2003: Bukholm I R K; Bondi J; Wiik P; Nesland J M; Andersen S N; Bakka A; Bukholm G
Presence of isolated tumour cells in mesenteric lymph nodes predicts poor prognosis in patients with stage II colon cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2003;29(10):862-6.
2003: Wu Qinghua; Shi Huirong; Suo Zhenhe; Nesland Jahn M
5'-CpG island methylation of the FHIT gene is associated with reduced protein expression and higher clinical stage in cervical carcinomas.
Ultrastructural pathology 2003;27(6):417-22.
2003: Looijenga Leendert H J; de Leeuw Hubert; van Oorschot Monique; van Gurp Ruud J H L M; Stoop Hans; Gillis Ad J M; de Gouveia Brazao Carlos A; Weber Rob F A; Kirkels Wim J; van Dijk Thamar; von Lindern Marieke; Valk Peter; Lajos Geczy; Olah Edit; Nesland Jahn M; Fosså Sophie D; Oosterhuis J Wolter
Stem cell factor receptor (c-KIT) codon 816 mutations predict development of bilateral testicular germ-cell tumors.
Cancer research 2003;63(22):7674-8.
2003: Givant-Horwitz Vered; Davidson Ben; Lazarovici Philip; Schaefer Erik; Nesland Jahn M; Tropé Claes G; Reich Reuven
Mitogen-activated protein kinases (MAPK) as predictors of clinical outcome in serous ovarian carcinoma in effusions.
Gynecologic oncology 2003;91(1):160-72.
2003: Skotheim Rolf I; Abeler Vera M; Nesland Jahn M; Fosså Sophie D; Holm Ruth; Wagner Urs; Flørenes Vivi Ann; Aass Nina; Kallioniemi Olli P; Lothe Ragnhild A
Candidate genes for testicular cancer evaluated by in situ protein expression analyses on tissue microarrays.
Neoplasia (New York, N.Y.) 2003;5(5):397-404.
2003: Wiedswang G; Borgen E; Kåresen R; Kvalheim G; Nesland J M; Qvist H; Schlichting E; Sauer T; Janbu J; Harbitz T; Naume B
Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(18):3469-78.
2003: Fosså S D; Aass N; Heilo A; Daugaard G; E Skakkebaek N; Stenwig A E; Nesland J M; Looijenga L H J; Oosterhuis J W
Testicular carcinoma in situ in patients with extragonadal germ-cell tumours: the clinical role of pretreatment biopsy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(9):1412-8.
2003: Maelandsmo Gunhild M; Holm Ruth; Nesland Jahn M; Fodstad Øystein; Flørenes Vivi Ann
Reduced beta-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(9):3383-8.
2003: Flatmark Kjersti; Pedersen Kjetil Boye; Nesland Jahn M; Rasmussen Heidi; Aamodt Geir; Mikalsen Svein-Ole; Bjørnland Kristin; Fodstad Øystein; Maelandsmo Gunhild M
Nuclear localization of the metastasis-related protein S100A4 correlates with tumour stage in colorectal cancer.
The Journal of pathology 2003;200(5):589-95.
2003: Bukholm Ida R K; Husdal Anne; Nesland Jahn M; Langerød Anita; Bukholm Geir
Overexpression of cyclin A overrides the effect of p53 alterations in breast cancer patients with long follow-up time.
Breast cancer research and treatment 2003;80(2):199-206.
2003: Reed W; Hannisdal E; Skovlund E; Thoresen S; Lilleng P; Nesland J M
Pregnancy and breast cancer: a population-based study.
Virchows Archiv : an international journal of pathology 2003;443(1):44-50.
2003: Sudbø Jon; Ristimäki Ari; Sondresen Jan Erik; Kildal Wanja; Boysen Morten; Koppang Hanna S; Reith Albrecht; Risberg Björn; Nesland Jahn M; Bryne Magne
Cyclooxygenase-2 (COX-2) expression in high-risk premalignant oral lesions.
Oral oncology 2003;39(5):497-505.
2003: Davidson Ben; Reich Reuven; Lazarovici Philip; Nesland Jahn M; Skrede Martina; Risberg Björn; Tropé Claes G; Flørenes Vivi Ann
Expression and activation of the nerve growth factor receptor TrkA in serous ovarian carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(6):2248-59.
2003: Berner H S; Suo Z; Risberg B; Villman K; Karlsson M G; Nesland J M
Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomas.
Histopathology 2003;42(6):546-54.
2003: Bukholm I R K; Bukholm G; Holm R; Nesland J M
Association between histology grade, expression of HsMCM2, and cyclin A in human invasive breast carcinomas.
Journal of clinical pathology 2003;56(5):368-73.
2003: Reed Wenche; Sandstad Berit; Holm Ruth; Nesland Jahn M
The prognostic impact of hormone receptors and c-erbB-2 in pregnancy-associated breast cancer and their correlation with BRCA1 and cell cycle modulators.
International journal of surgical pathology 2003;11(2):65-74.
2003: Suo Zhenhe; Nesland Jahn M
Electron microscopy in diagnosis of spindle cell tumors.
Seminars in diagnostic pathology 2003;20(1):5-12.
2003: Ikonomou Ida Münster; Nesland Jahn M; Schjølseth Svein Arve; Heim Sverre; Delabie Jan
Mantle cell lymphoma with Homer-Wright rosettes.
Virchows Archiv : an international journal of pathology 2003;442(2):179-82.
2003: Diep Chieu B; Parada Luis A; Teixeira Manuel R; Eknaes Mette; Nesland Jahn M; Johansson Bertil; Lothe Ragnhild A
Genetic profiling of colorectal cancer liver metastases by combined comparative genomic hybridization and G-banding analysis.
Genes, chromosomes & cancer 2003;36(2):189-97.
2003: Torlakovic Emina; Skovlund Eva; Snover Dale C; Torlakovic Goran; Nesland Jahn M
Morphologic reappraisal of serrated colorectal polyps.
The American journal of surgical pathology 2003;27(1):65-81.
2003: Lilleby Wolfgang; Nesland Jahn M; Fosså Sophie D; Torlakovic Goran; Waehre Håkon; Kvalheim Gunnar
The prognostic impact of cytokeratin-positive cells in bone marrow of patients with localized prostate cancer.
International journal of cancer. Journal international du cancer 2003;103(1):91-6.
2003: Davidson Ben; Givant-Horwitz Vered; Lazarovici Philip; Risberg Björn; Nesland Jahn M; Trope Claes G; Schaefer Erik; Reich Reuven
Matrix metalloproteinases (MMP), EMMPRIN (extracellular matrix metalloproteinase inducer) and mitogen-activated protein kinases (MAPK): co-expression in metastatic serous ovarian carcinoma.
Clinical & experimental metastasis 2003;20(7):621-31.
2003: Hjortland G O; Bjørnland K; Pettersen S; Garman-Vik S S; Emilsen E; Nesland J M; Fodstad O; Engebraaten O
Modulation of glioma cell invasion and motility by adenoviral gene transfer of PAI-1.
Clinical & experimental metastasis 2003;20(4):301-9.
2002: Bassarova Assia V; Sedloev Theophil; Christova Svetlana L; Trifonov Dimitar Y; Nesland Jahn M
Invasive lobular carcinoma in a hypoplastic breast.
Ultrastructural pathology 2002;26(6):411-4.
2002: Pedersen K B; Nesland J M; Fodstad Ø; Maelandsmo G M
Expression of S100A4, E-cadherin, alpha- and beta-catenin in breast cancer biopsies.
British journal of cancer 2002;87(11):1281-6.
2002: Friesen Scott A; Hjortland Geir Olav; Madsen Steen J; Hirschberg Henry; Engebraten Olav; Nesland Jahn M; Peng Qian
5-Aminolevulinic acid-based photodynamic detection and therapy of brain tumors (review).
International journal of oncology 2002;21(3):577-82.
2002: Karbova Eleonora; Davidson Ben; Metodiev Krassimir; Tropé Claes G; Nesland Jahn M
Adenomatous polyposis coli (APC) protein expression in primary and metastatic serous ovarian carcinoma.
International journal of surgical pathology 2002;10(3):175-80.
2002: Johannessen Hans-Olaf; Dale Einar; Hellebust Taran P; Olsen Dag R; Nesland Jahn M; Giercksky Karl-Erik
Modeling volume effects of experimental brachytherapy in the rat rectum: uncovering the limitations of a radiobiologic concept.
International journal of radiation oncology, biology, physics 2002;53(4):1014-22.
2002: Davidson Ben; Reich Reuven; Risberg Bjørn; Nesland Jahn M
The biological role and regulation of matrix metalloproteinases (MMP) in cancer.
Arkhiv patologii 2002;64(3):47-53.
2002: Suo Zhenhe; Nesland Jahn M
Type 1 protein tyrosine kinases in breast carcinoma: a review.
Ultrastructural pathology 2002;26(3):125-35.
2002: Yang Huihua; Berner Aasmund; Mei Qiang; Giercksky Karl-Erik; Warloe Trond; Yang Guanrui; Cui Jianguo; Suo Zhenhe; Zhang Sanshen; Nesland Jahn M
Cytologic screening for esophageal cancer in a high-risk population in Anyang County, China.
Acta cytologica 2002;46(3):445-52.
2002: Suo Zhenhe; Risberg Bjørn; Karlsson Mats G; Villman Kenneth; Skovlund Eva; Nesland Jahn M
The expression of EGFR family ligands in breast carcinomas.
International journal of surgical pathology 2002;10(2):91-9.
2002: Bukholm Ida R K; Bukholm Geir; Nesland Jahn M
Reduced expression of both Bax and Bcl-2 is independently associated with lymph node metastasis in human breast carcinomas.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2002;110(3):214-20.
2002: Suo Zhenhe; Nesland Jahn M
Barrett's esophagus: intestinal metaplasia or phenotypic shift of undifferentiated elements in the stem cells.
Ultrastructural pathology 2002;26(2):53-4.
2002: Meza-Zepeda Leonardo A; Forus Anne; Lygren Birgitte; Dahlberg Anine B; Godager Linda H; South Andrew P; Marenholz Ingo; Lioumi Maria; Flørenes Vivi Ann; Maelandsmo Gunhild M; Serra Massimo; Mischke Dietmar; Nizetic Dean; Ragoussis Jiannis; Tarkkanen Maija; Nesland Jahn M; Knuutila Sakari; Myklebost Ola
Positional cloning identifies a novel cyclophilin as a candidate amplified oncogene in 1q21.
Oncogene 2002;21(14):2261-9.
2002: Davidson Ben; Goldberg Iris; Gotlieb Walter H; Kopolovic Juri; Ben-Baruch Gilad; Nesland Jahn M; Reich Reuven
The prognostic value of metalloproteinases and angiogenic factors in ovarian carcinoma.
Molecular and cellular endocrinology 2002;187(1-2):39-45.
2002: Davidson Ben; Goldberg Iris; Givant-Horwitz Vered; Nesland Jahn M; Berner Aasmund; Bryne Magne; Risberg Bjørn; Kopolovic Juri; Kristensen Gunnar B; Tropé Claes G; van de Putte Gregg; Reich Reuven
Caveolin-1 expression in ovarian carcinoma is MDR1 independent.
American journal of clinical pathology 2002;117(2):225-34.
2002: Kraggerud Sigrid Marie; Aman Pierre; Holm Ruth; Stenwig Anna Elisabeth; Fosså Sophie Dorothea; Nesland Jahn M; Lothe Ragnhild A
Alterations of the fragile histidine triad gene, FHIT, and its encoded products contribute to testicular germ cell tumorigenesis.
Cancer research 2002;62(2):512-7.
2002: Suo Zhenhe; Risberg Bjørn; Kalsson Mats G; Willman Kenneth; Tierens Anne; Skovlund Eva; Nesland Jahn M
EGFR family expression in breast carcinomas. c-erbB-2 and c-erbB-4 receptors have different effects on survival.
The Journal of pathology 2002;196(1):17-25.
2002: Scheistrøen M; Nesland J M; Tropé C
Have patients with early squamous carcinoma of the vulva been overtreated in the past? The Norwegian experience 1977-1991.
European journal of gynaecological oncology 2002;23(2):93-103.
2002: Davidson Ben; Reich Reuven; Kopolovic Juri; Berner Aasmund; Nesland Jahn M; Kristensen Gunnar B; Tropé Claes G; Bryne Magne; Risberg Bjørn; van de Putte Gregg; Goldberg Iris
Interleukin-8 and vascular endothelial growth factor mRNA and protein levels are down-regulated in ovarian carcinoma cells in serous effusions.
Clinical & experimental metastasis 2002;19(2):135-44.
2001: Thorstensen L; Qvist H; Nesland J M; Giercksky K E; Lothe R A
Identification of two potential suppressor gene regions on chromosome arm 14q that are commonly lost in advanced colorectal carcinomas.
Scandinavian journal of gastroenterology 2001;36(12):1327-31.
2001: Naume B; Borgen E; Kvalheim G; Kåresen R; Qvist H; Sauer T; Kumar T; Nesland J M
Detection of isolated tumor cells in bone marrow in early-stage breast carcinoma patients: comparison with preoperative clinical parameters and primary tumor characteristics.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(12):4122-9.
2001: Flørenes V A; Maelandsmo G M; Faye R; Nesland J M; Holm R
Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome.
The Journal of pathology 2001;195(5):530-6.
2001: Davidson B; Risberg B; Goldberg I; Nesland J M; Berner A; Tropé C G; Kristensen G B; Bryne M; Reich R
Ets-1 mRNA expression in effusions of serous ovarian carcinoma patients is a marker of poor outcome.
The American journal of surgical pathology 2001;25(12):1493-500.
2001: Davidson B; Lazarovici P; Ezersky A; Nesland J M; Berner A; Risberg B; Tropé C G; Kristensen G B; Goscinski M; van de Putte G; Reich R
Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(11):3457-64.
2001: Davidson B; Risberg B; Berner A; Nesland J M; Tropé C G; Kristensen G B; Bryne M; Goscinski M; van de Putte G; Flørenes V A
Expression of cell cycle proteins in ovarian carcinoma cells in serous effusions-biological and prognostic implications.
Gynecologic oncology 2001;83(2):249-56.
2001: Davidson B; Reich R; Berner A; Givant-Horwitz V; Goldberg I; Risberg B; Kristensen G B; Trope C G; Bryne M; Kopolovic J; Nesland J M
Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levels.
European journal of cancer (Oxford, England : 1990) 2001;37(16):2040-9.
2001: Forus A; D'Angelo A; Henriksen J; Merla G; Maelandsmo G M; Flørenes V A; Olivieri S; Bjerkehagen B; Meza-Zepeda L A; del Vecchio Blanco F; Müller C; Sanvito F; Kononen J; Nesland J M; Fodstad Ø; Reymond A; Kallioniemi O P; Arrigoni G; Ballabio A; Myklebost O; Zollo M
Amplification and overexpression of PRUNE in human sarcomas and breast carcinomas-a possible mechanism for altering the nm23-H1 activity.
Oncogene 2001;20(47):6881-90.
2001: Bukholm I R; Bukholm G; Nesland J M
Coexpression of cyclin A and beta-catenin and survival in breast cancer patients.
International journal of cancer. Journal international du cancer 2001;94(1):148-9.
2001: Suo Z; Bjaamer A; Ottestad L; Nesland J M
Expression of EGFR family and steroid hormone receptors in ductal carcinoma in situ of the breast.
Ultrastructural pathology 2001;25(5):349-56.
2001: Peng Q; Soler A M; Warloe T; Nesland J M; Giercksky K E
Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate.
Journal of photochemistry and photobiology. B, Biology 2001;62(3):140-5.
2001: Borgen E; Naume B; Nesland J M; Nowels K W; Pavlak N; Ravkin I; Goldbard S
Use of automated microscopy for the detection of disseminated tumor cells in bone marrow samples.
Cytometry 2001;46(4):215-21.
2001: Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky K E; Nesland J M
Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
Cancer research 2001;61(15):5824-32.
2001: Suo Z; Yang H; Mei Q; Skovlund E; Cui J; Nesland J M
Type 1 protein tyrosine kinases in Chinese breast carcinomas: a clinicopathologic study.
International journal of surgical pathology 2001;9(3):177-87.
2001: Suo Z; Berner H S; Risberg B; Karlsson M G; Nesland J M
Estrogen receptor-alpha and C-ERBB-4 expression in breast carcinomas.
Virchows Archiv : an international journal of pathology 2001;439(1):62-9.
2001: Bukholm I R; Bukholm G; Nesland J M
Over-expression of cyclin A is highly associated with early relapse and reduced survival in patients with primary breast carcinomas.
International journal of cancer. Journal international du cancer 2001;93(2):283-7.
2001: Davidson B; Nesland J M; Goldberg I; Kopolovic J; Gotlieb W H; Bryne M; Ben-Baruch G; Berner A; Reich R
Caveolin-1 expression in advanced-stage ovarian carcinoma--a clinicopathologic study.
Gynecologic oncology 2001;81(2):166-71.
2001: Davidson B; Goldberg I; Berner A; Nesland J M; Givant-Horwitz V; Bryne M; Risberg B; Kristensen G B; Tropé C G; Kopolovic J; Reich R
Expression of membrane-type 1, 2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusions.
American journal of clinical pathology 2001;115(4):517-24.
2001: Davidson B; Reich R; Goldberg I; Gotlieb W H; Kopolovic J; Berner A; Ben-Baruch G; Bryne M; Nesland J M
Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(3):551-7.
2001: Berner H S; Nesland J M
Expression of CD44 isoforms in infiltrating lobular carcinoma of the breast.
Breast cancer research and treatment 2001;65(1):23-9.
2000: Davidson B; Berner A; Nesland J M; Risberg B; Berner H S; Tropè C G; Kristensen G B; Bryne M; Ann Florenes V
E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions.
The Journal of pathology 2000;192(4):460-9.
2000: Davidson B; Gotlieb W H; Ben-Baruch G; Nesland J M; Bryne M; Goldberg I; Kopolovic J; Berner A
E-Cadherin complex protein expression and survival in ovarian carcinoma.
Gynecologic oncology 2000;79(3):362-71.
2000: Thorstensen L; Qvist H; Heim S; Liefers G J; Nesland J M; Giercksky K E; Lothe R A
Evaluation of 1p losses in primary carcinomas, local recurrences and peripheral metastases from colorectal cancer patients.
Neoplasia (New York, N.Y.) 2000;2(6):514-22.
2000: Suo Z; Nesland J M
Phyllodes tumor of the breast: EGFR family expression and relation to clinicopathological features.
Ultrastructural pathology 2000;24(6):371-81.
2000: Baekelandt M; Holm R; Nesland J M; Tropé C G; Kristensen G B
Expression of apoptosis-related proteins is an independent determinant of patient prognosis in advanced ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(22):3775-81.
2000: Davidson B; Berner A; Nesland J M; Risberg B; Kristensen G B; Tropé C G; Bryne M
Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions.
Human pathology 2000;31(9):1081-7.
2000: Flørenes V A; Faye R S; Maelandsmo G M; Nesland J M; Holm R
Levels of cyclin D1 and D3 in malignant melanoma: deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(9):3614-20.
2000: Risberg B; Davidson B; Dong H P; Nesland J M; Berner A
Flow cytometric immunophenotyping of serous effusions and peritoneal washings: comparison with immunocytochemistry and morphological findings.
Journal of clinical pathology 2000;53(7):513-7.
2000: Berner H S; Davidson B; Berner A; Risberg B; Nesland J M
Differential expression of CD44s and CD44v3-10 in adenocarcinoma cells and reactive mesothelial cells in effusions.
Virchows Archiv : an international journal of pathology 2000;436(4):330-5.
2000: Davidson B; Gotlieb W H; Ben-Baruch G; Kopolovic J; Goldberg I; Nesland J M; Berner A; Bjåmer A; Bryne M
Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastases-A clinicopathologic study.
Gynecologic oncology 2000;77(1):35-43.
2000: Baekelandt M M; Holm R; Nesland J M; Tropé C G; Kristensen G B
P-glycoprotein expression is a marker for chemotherapy resistance and prognosis in advanced ovarian cancer.
Anticancer research 2000;20(2B):1061-7.
2000: Bukholm I K; Nesland J M; Børresen-Dale A L
Re-expression of E-cadherin, alpha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients [seecomments]
The Journal of pathology 2000;190(1):15-9.
2000: Davidson B; Goldberg I; Kopolovic J; Gotlieb W H; Givant-Horwitz V; Nesland J M; Berner A; Ben-Baruch G; Bryne M; Reich R
Expression of angiogenesis-related genes in ovarian carcinoma--a clinicopathologic study.
Clinical & experimental metastasis 2000;18(6):501-7.
2000: Berner H S; Davidson B; Berner A; Risberg B; Kristensen G B; Trope C G; Van de Putte G; Nesland J M
Expression of CD44 in effusions of patients diagnosed with serous ovarian carcinoma--diagnostic and prognostic implications.
Clinical & experimental metastasis 2000;18(2):197-202.
1999: Baekelandt M; Holm R; Tropé C G; Nesland J M; Kristensen G B
The significance of metastasis-related factors cathepsin-D and nm23 in advanced ovarian cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(11):1335-41.
1999: Bjerkehagen B; Dietrich C; Reed W; Micci F; Saeter G; Berner A; Nesland J M; Heim S
Extraskeletal myxoid chondrosarcoma: multimodal diagnosis and identification of a new cytogenetic subgroup characterized by t(9;17)(q22;q11).
Virchows Archiv : an international journal of pathology 1999;435(5):524-30.
1999: Baekelandt M; Holm R; Tropé C G; Nesland J M; Kristensen G B
Lack of independent prognostic significance of p21 and p27 expression in advanced ovarian cancer: an immunohistochemical study.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10):2848-53.
1999: Baekelandt M; Kristensen G B; Tropé C G; Nesland J M; Holm R
Epidermal growth factor receptor expression has no independent prognostic significance in advanced ovarian cancer.
Anticancer research 1999;19(5C):4469-74.
1999: Raabe N K; Sauer T; Erichsen A; Nesland J M; Fossaa S D
Breast cancer in the contralateral breast: incidence and histopathology after unilateral radical treatment of the first breast cancer.
Oncology reports 1999;6(5):1001-7.
1999: Reed W; Flørems V A; Holm R; Hannisdal E; Nesland J M
Elevated levels of p27, p21 and cyclin D1 correlate with positive oestrogen and progesterone receptor status in node-negative breast carcinoma patients.
Virchows Archiv : an international journal of pathology 1999;435(2):116-24.
1999: Baekelandt M; Kristensen G B; Nesland J M; Tropé C G; Holm R
Clinical significance of apoptosis-related factors p53, Mdm2, and Bcl-2 in advanced ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(7):2061.
1999: Skomedal H; Kristensen G B; Nesland J M; Børresen-Dale A L; Tropé C; Holm R
TP53 alterations in relation to the cell cycle-associated proteins p21, cyclin D1, CDK4, RB, MDM2, and EGFR in cancers of the uterine corpus.
The Journal of pathology 1999;187(5):556-62.
1999: Scheistrøen M; Tropé C; Pettersen E O; Nesland J M
p53 protein expression in squamous cell carcinoma of the vulva.
Cancer 1999;85(5):1133-8.
1999: Noodt B B; Berg K; Stokke T; Peng Q; Nesland J M
Different apoptotic pathways are induced from various intracellular sites by tetraphenylporphyrins and light.
British journal of cancer 1999;79(1):72-81.
1999: Hennig E M; Suo Z; Thoresen S; Holm R; Kvinnsland S; Nesland J M
Human papillomavirus 16 in breast cancer of women treated for high grade cervical intraepithelial neoplasia (CIN III).
Breast cancer research and treatment 1999;53(2):121-35.
1999: Davidson B; Goldberg I; Gotlieb W H; Kopolovic J; Ben-Baruch G; Nesland J M; Berner A; Bryne M; Reich R
High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma.
Clinical & experimental metastasis 1999;17(10):799-808.
1999: Hennig E M; Kvinnsland S; Holm R; Nesland J M
Significant difference in p53 and p21 protein immunoreactivity in HPV 16 positive and HPV negative breast carcinomas.
Acta oncologica (Stockholm, Sweden) 1999;38(7):931-8.
1999: Kvalheim G; Naume B; Nesland J M
Minimal residual disease in breast cancer.
Cancer metastasis reviews 1999;18(1):101-8.
1999: Hennig E M; Suo Z; Karlsen F; Holm R; Thoresen S; Nesland J M
HPV positive bronchopulmonary carcinomas in women with previous high-grade cervical intraepithelial neoplasia (CIN III).
Acta oncologica (Stockholm, Sweden) 1999;38(5):639-47.
1998: Suo Z; Emilsen E; Tveit K M; Nesland J M
Type 1 protein tyrosine kinases in benign and malignant breast lesions.
Histopathology 1998;33(6):514-21.
1998: Naume B; Borgen E; Nesland J M; Beiske K; Gilen E; Renolen A; Ravnås G; Qvist H; Kåresen R; Kvalheim G
Increased sensitivity for detection of micrometastases in bone-marrow/peripheral-blood stem-cell products from breast-cancer patients by negative immunomagnetic separation.
International journal of cancer. Journal international du cancer 1998;78(5):556-60.
1998: Nedelcheva Kristensen V; Andersen T I; Erikstein B; Geitvik G; Skovlund E; Nesland J M; Børresen-Dale A L
Single tube multiplex polymerase chain reaction genotype analysis of GSTM1, GSTT1 and GSTP1: relation of genotypes to TP53 tumor status and clinicopathological variables in breast cancer patients.
Pharmacogenetics 1998;8(5):441-7.
1998: Bukholm I K; Berner J M; Nesland J M; Børresen-Dale A L
Expression of cyclin Ds in relation to p53 status in human breast carcinomas.
Virchows Archiv : an international journal of pathology 1998;433(3):223-8.
1998: Borgen E; Beiske K; Trachsel S; Nesland J M; Kvalheim G; Herstad T K; Schlichting E; Qvist H; Naume B
Immunocytochemical detection of isolated epithelial cells in bone marrow: non-specific staining and contribution by plasma cells directly reactive to alkaline phosphatase.
The Journal of pathology 1998;185(4):427-34.
1998: Bukholm I K; Nesland J M; Kåresen R; Jacobsen U; Børresen-Dale A L
E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma.
The Journal of pathology 1998;185(3):262-6.
1998: Noodt B B; Rodal G H; Wainwright M; Peng Q; Horobin R; Nesland J M; Berg K
Apoptosis induction by different pathways with methylene blue derivative and light from mitochondrial sites in V79 cells.
International journal of cancer. Journal international du cancer 1998;75(6):941-8.
1997: Giercksky H E; Thorstensen L; Qvist H; Nesland J M; Lothe R A
Comparison of genetic changes in frozen biopsies and microdissected archival material from the same colorectal liver metastases.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1997;6(6):318-25.
1997: Kareem B N; Karlsen F; Holm R; Hennig E M; Suo Z; Emilsen E; Hellesylt E; Nesland J M
A novel grid polymerase chain reaction (G-PCR) approach at ultrastructural level to detect target DNA in cell cultures and tissues.
The Journal of pathology 1997;183(4):486-93.
1997: Nordal R R; Kristensen G B; Stenwig A E; Nesland J M; Pettersen E O; Trope C G
An evaluation of prognostic factors in uterine carcinosarcoma.
Gynecologic oncology 1997;67(3):316-21.
1997: Bukholm I K; Nesland J M; Kåresen R; Jacobsen U; Børresen-Dale A L
Expression of E-cadherin and its relation to the p53 protein status in human breast carcinomas.
Virchows Archiv : an international journal of pathology 1997;431(5):317-21.
1997: Holm R; Flørenes V A; Erikstein B; Nesland J M
Expression of stromelysin-3 in medullary carcinoma of the breast.
Anticancer research 1997;17(5B):3725-7.
1997: Bukholm I K; Nesland J M; Kåresen R; Jacobsen U; Børresen-Dale A L
Interaction between bcl-2 and p21 (WAF1/CIP1) in breast carcinomas with wild-type p53.
International journal of cancer. Journal international du cancer 1997;73(1):38-41.
1997: Peng Q; Warloe T; Berg K; Moan J; Kongshaug M; Giercksky K E; Nesland J M
5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges.
Cancer 1997;79(12):2282-308.
1997: Laake K; Odegård A; Andersen T I; Bukholm I K; Kåresen R; Nesland J M; Ottestad L; Shiloh Y; Børresen-Dale A L
Loss of heterozygosity at 11q23.1 in breast carcinomas: indication for involvement of a gene distal and close to ATM.
Genes, chromosomes & cancer 1997;18(3):175-80.
1997: Helland A; Børresen-Dale A L; Peltomäki P; Hektoen M; Kristensen G B; Nesland J M; de la Chapelle A; Lothe R A
Microsatellite instability in cervical and endometrial carcinomas.
International journal of cancer. Journal international du cancer 1997;70(5):499-501.
1997: Bukholm I K; Nesland J M; Kåresen R; Jacobsen U; Børresen A L
Relationship between abnormal p53 protein and failure to express p21 protein in human breast carcinomas.
The Journal of pathology 1997;181(2):140-5.
1997: Peng Q; Berg K; Moan J; Kongshaug M; Nesland J M
5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research.
Photochemistry and photobiology 1997;65(2):235-51.
1997: Scheistrøen M; Tropé C; Kaern J; Pettersen E O; Alfsen G C; Nesland J M
DNA ploidy and expression of p53 and C-erbB-2 in extramammary Paget's disease of the vulva.
Gynecologic oncology 1997;64(1):88-92.
1996: Thorstensen L; Qvist H; Nesland J M; Giercksky K E; Lothe R A
Allelotype profiles of local recurrences and distant metastases from colorectal-cancer patients.
International journal of cancer. Journal international du cancer 1996;69(6):452-6.
1996: Noodt B B; Berg K; Stokke T; Peng Q; Nesland J M
Apoptosis and necrosis induced with light and 5-aminolaevulinic acid-derived protoporphyrin IX.
British journal of cancer 1996;74(1):22-9.
1996: Peng Q; Moan J; Warloe T; Iani V; Steen H B; Bjørseth A; Nesland J M
Build-up of esterified aminolevulinic-acid-derivative-induced porphyrin fluorescence in normal mouse skin.
Journal of photochemistry and photobiology. B, Biology 1996;34(1):95-6.
1996: Peng Q; Moan J; Nesland J M
Correlation of subcellular and intratumoral photosensitizer localization with ultrastructural features after photodynamic therapy.
Ultrastructural pathology 1996;20(2):109-129.
1996: Chitemerere M; Andersen T I; Holm R; Karlsen F; Børresen A L; Nesland J M
TP53 alterations in atypical ductal hyperplasia and ductal carcinoma in situ of the breast.
Breast cancer research and treatment 1996;41(2):103-9.
1995: Suo Z; Su W; Holm R; Nesland J M
Lack of expression of c-erbB-2 oncoprotein in human esophageal squamous cell carcinomas.
Anticancer research 1995;15(6B):2797-8.
1995: Peng Q; Warloe T; Moan J; Heyerdahl H; Steen H B; Nesland J M; Giercksky K E
Distribution of 5-aminolevulinic acid-induced porphyrins in noduloulcerative basal cell carcinoma.
Photochemistry and photobiology 1995;62(5):906-13.
1995: Lothe R A; Peltomäki P; Tommerup N; Fosså S D; Stenwig A E; Børresen A L; Nesland J M
Molecular genetic changes in human male germ cell tumors.
Laboratory investigation; a journal of technical methods and pathology 1995;73(5):606-14.
1995: Berner A; Geitvik G; Karlsen F; Fosså S D; Nesland J M; Børresen A L
TP53 mutations in prostatic cancer. Analysis of pre- and post-treatment archival formalin-fixed tumour tissue.
The Journal of pathology 1995;176(3):299-308.
1995: Skomedal H; Kristensen G; Helland A; Nesland J M; Kooi S; Børresen A L; Holm R
TP53 gene mutations and protein accumulation in primary vaginal carcinomas.
British journal of cancer 1995;72(1):129-33.
1995: Peng Q; Moan J; Ma L W; Nesland J M
Uptake, localization, and photodynamic effect of meso-tetra(hydroxyphenyl)porphine and its corresponding chlorin in normal and tumor tissues of mice bearing mammary carcinoma.
Cancer research 1995;55(12):2620-6.
1995: Helseth A; Haug E; Nesland J M; Siegal G P; Fodstad O; Bautch V L
Endocrine and metabolic characteristics of polyoma large T transgenic mice that develop ACTH-producing pituitary tumors.
Journal of neurosurgery 1995;82(5):879-85.
1995: Lothe R A; Slettan A; Saeter G; Brøgger A; Børresen A L; Nesland J M
Alterations at chromosome 17 loci in peripheral nerve sheath tumors.
Journal of neuropathology and experimental neurology 1995;54(1):65-73.
1995: Berner A; Waere H; Nesland J M; Paus E; Danielsen H E; Fosså S D
DNA ploidy, serum prostate specific antigen, histological grade and immunohistochemistry as predictive parameters of lymph node metastases in T1-T3/M0 prostatic adenocarcinoma.
British journal of urology 1995;75(1):26-32.
1995: Andersen T I; Paus E; Nesland J M; McKenzie S J; Børresen A L
Detection of c-erbB-2 related protein in sera from breast cancer patients. Relationship to ERBB2 gene amplification and c-erbB-2 protein overexpression in tumour.
Acta oncologica (Stockholm, Sweden) 1995;34(4):499-504.
1995: Holm R; Høie J; Kaalhus O; Nesland J M
Immunohistochemical detection of nm23/NDP kinase and cathepsin D in medullary carcinomas of the thyroid gland.
Virchows Archiv : an international journal of pathology 1995;427(3):289-94.
1994: Høie J; Jørgensen O G; Nesland J M; Møller P; Bjøro K
[Medullary thyroid carcinoma--familial or sporadic disease?]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1994;114(25):2951-4.
1994: Giercksky K E; Qvist H; Giercksky T C; Warloe T; Nesland J M
Multiple glove powder granulomas masquerading as peritoneal carcinomatosis.
Journal of the American College of Surgeons 1994;179(3):299-304.
1994: Rosenberg C; Andersen T I; Nesland J M; Lier M E; Brøgger A; Børresen A L
Genetic alterations of chromosome 17 in human breast carcinoma studied by fluorescence in situ hybridization and molecular DNA techniques.
Cancer genetics and cytogenetics 1994;75(1):1-5.
1994: Holm R; Tanum G; Karlsen F; Nesland J M
Prevalence and physical state of human papillomavirus DNA in anal carcinomas.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1994;7(4):449-53.
1994: Berner A; Harvei S; Tretli S; Fosså S D; Nesland J M
Prostatic carcinoma: a multivariate analysis of prognostic factors.
British journal of cancer 1994;69(5):924-30.
1994: Hall W A; Myklebust A; Godal A; Nesland J M; Fodstad O
In vivo efficacy of intrathecal transferrin-Pseudomonas exotoxin A immunotoxin against LOX melanoma.
Neurosurgery 1994;34(4):649-55; discussion 655-6.
1994: Holm R; Nesland J M
Retinoblastoma and p53 tumour suppressor gene protein expression in carcinomas of the thyroid gland.
The Journal of pathology 1994;172(3):267-72.
1994: Reed W; Bryne M; Clausen H; Dabelsteen E; Nesland J M
Simple mucins (T, sialosyl-T, Tn and sialosyl-Tn) are not diagnostic for malignant breast lesions.
Anticancer research 1994;14(2B):609-15.
1994: Abeler V M; Holm R; Nesland J M; Kjørstad K E
Small cell carcinoma of the cervix. A clinicopathologic study of 26 patients.
Cancer 1994;73(3):672-7.
1994: Flørenes V A; Oyjord T; Holm R; Skrede M; Børresen A L; Nesland J M; Fodstad O
TP53 allele loss, mutations and expression in malignant melanoma.
British journal of cancer 1994;69(2):253-9.
1994: Bjerkehagen B; Fosså S D; Raabe N; Holm R; Nesland J M
Transitional cell carcinoma of the renal pelvis and its expression of p53 protein, c-erbB-2 protein, neuron-specific enolase, Phe 5, chromogranin, laminin and collagen type IV.
European urology 1994;26(4):334-9.
1993: Berner A; Danielsen H E; Juul N O; Juul M E; Pettersen E O; Reith A; Nesland J M; Fosså S D
Caveats in the estimation of DNA-ploidy in paraffin embedded specimens of primary prostate cancer and lymph node metastases by flow and image cytometry.
Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology 1993;5(6):339-52.
1993: Helland A; Holm R; Kristensen G; Kaern J; Karlsen F; Trope C; Nesland J M; Børresen A L
Genetic alterations of the TP53 gene, p53 protein expression and HPV infection in primary cervical carcinomas.
The Journal of pathology 1993;171(2):105-14.
1993: Peng Q; Brown S B; Moan J; Nesland J M; Wainwright M; Griffiths J; Dixon B; Cruse-Sawyer J; Vernon D
Biodistribution of a methylene blue derivative in tumor and normal tissues of rats.
Journal of photochemistry and photobiology. B, Biology 1993;20(1):63-71.
1993: Fosså S D; Berner A A; Jacobsen A B; Waehre H; Kvarstein B; Urnes T; Ogreid P; Johansen T E; Silde J; Nesland J M
Clinical significance of DNA ploidy and S-phase fraction and their relation to p53 protein, c-erbB-2 protein and HCG in operable muscle-invasive bladder cancer.
British journal of cancer 1993;68(3):572-8.
1993: Andersen T I; Holm R; Nesland J M; Heimdal K R; Ottestad L; Børresen A L
Prognostic significance of TP53 alterations in breast carcinoma.
British journal of cancer 1993;68(3):540-8.
1993: Berner A; Danielsen H E; Pettersen E O; Fosså S D; Reith A; Nesland J M
DNA distribution in the prostate. Normal gland, benign and premalignant lesions, and subsequent adenocarcinomas.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 1993;15(4):247-52.
1993: Berner A; Nesland J M; Waehre H; Silde J; Fosså S D
Hormone resistant prostatic adenocarcinoma. An evaluation of prognostic factors in pre- and post-treatment specimens.
British journal of cancer 1993;68(2):380-4.
1993: Suo Z; Holm R; Nesland J M
Squamous cell carcinomas. An immunohistochemical study of cytokeratins and involucrin in primary and metastatic tumours.
Histopathology 1993;23(1):45-54.
1993: Holm R; Abeler V M; Skomedal H; Nesland J M
Overexpression of p53 protein and c-erbB-2 protein in small cell carcinoma of the cervix uteri.
Zentralblatt für Pathologie 1993;139(2):153-6.
1993: Ottestad L; Pettersen E O; Nesland J M; Hannisdal E; Fosså S D; Tveit K M
Flow cytometric DNA analysis as prognostic factor in human breast carcinoma.
Pathology, research and practice 1993;189(4):405-10.
1993: Suo Z; Qvist H; Su W; Holm R; Giercksky K E; Nesland J M
Undifferentiated carcinoma: an immunohistochemical and ultrastructural study.
Anticancer research 1993;13(3):643-9.
1993: Reed W; Erikstein B K; Funderud S; Lilleng R; Tvedt K; Nesland J M
CDw75 antigen expression in breast lesions.
Pathology, research and practice 1993;189(4):394-8.
1993: Pettersen E O; Larsen R O; Dornish J M; Børretzen B; Juul M E; Aastveit T E; Nesland J M; Rofstad E K; Oftebro R
Tumour necrotisation in nude mice xenografts by the reversible protein synthesis inhibitor zilascorb(2H).
British journal of cancer 1993;67(4):650-6.
1993: Berner A; Jacobsen A B; Fosså S D; Nesland J M
Expression of c-erbB-2 protein, neuron-specific enolase and DNA flow cytometry in locally advanced transitional cell carcinoma of the urinary bladder.
Histopathology 1993;22(4):327-33.
1993: Andreassen A; Oyjord T; Hovig E; Holm R; Flørenes V A; Nesland J M; Myklebost O; Høie J; Bruland O S; Børresen A L
p53 abnormalities in different subtypes of human sarcomas.
Cancer research 1993;53(3):468-71.
1993: Holm R; Skomedal H; Helland A; Kristensen G; Børresen A L; Nesland J M
Immunohistochemical analysis of p53 protein overexpression in normal, premalignant, and malignant tissues of the cervix uteri.
The Journal of pathology 1993;169(1):21-6.
1993: Holm R; Helseth A; Nesland J M; Bautch V L
ACTH-producing pituitary tumors in transgenic mice. An ultrastructural and immunoelectron microscopic study.
Journal of submicroscopic cytology and pathology 1993;25(1):29-36.
1993: Helseth A; Bautch V L; Haug E; Holm R; Nesland J M; Fodstad O
[Transgenic mice as animal model of Cushing's syndrome]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1993;113(2):206-10.
1993: Ottestad L; Andersen T I; Nesland J M; Skrede M; Tveit K M; Nustad K; Børresen A L
Amplification of c-erbB-2, int-2 and c-myc genes in node-negative breast carcinomas. Relationship to prognosis.
Acta oncologica (Stockholm, Sweden) 1993;32(3):289-94.
1992: Vergote I; Larsen R H; de Vos L; Nesland J M; Bruland O; Bjørgum J; Alstad J; Tropé C; Nustad K
Therapeutic efficacy of the alpha-emitter 211At bound on microspheres compared with 90Y and 32P colloids in a murine intraperitoneal tumor model.
Gynecologic oncology 1992;47(3):366-72.
1992: Peng Q; Moan J; Warloe T; Nesland J M; Rimington C
Distribution and photosensitizing efficiency of porphyrins induced by application of exogenous 5-aminolevulinic acid in mice bearing mammary carcinoma.
International journal of cancer. Journal international du cancer 1992;52(3):433-43.
1992: Lothe R A; Fossli T; Danielsen H E; Stenwig A E; Nesland J M; Gallie B; Børresen A L
Molecular genetic studies of tumor suppressor gene regions on chromosomes 13 and 17 in colorectal tumors.
Journal of the National Cancer Institute 1992;84(14):1100-8.
1992: Vergote I; De Vos L; Fjeld J; Nesland J; Kierulf B; Michaelsen T; Nustad K
B-cell hybridoma as intraperitoneal tumor model: correlation between tumor growth and monoclonal antibody production.
Hybridoma 1992;11(3):323-31.
1992: Holm R; Karlsen F; Nesland J M
In situ hybridization with nonisotopic probes using different detection systems.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1992;5(3):315-9.
1992: Andersen T I; Gaustad A; Ottestad L; Farrants G W; Nesland J M; Tveit K M; Børresen A L
Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas.
Genes, chromosomes & cancer 1992;4(2):113-21.
1992: Lilleng R; Hagmar B M; Nesland J M
C-erbB-2 protein and neuroendocrine expression in intraductal carcinomas of the breast.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1992;5(1):41-7.
1991: Fosså S D; Nesland J M; Pettersen E O; Amellem O; Waehre H; Heimdal K
DNA ploidy in primary testicular cancer.
British journal of cancer 1991;64(5):948-52.
1991: Børresen A L; Hovig E; Smith-Sørensen B; Malkin D; Lystad S; Andersen T I; Nesland J M; Isselbacher K J; Friend S H
Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(19):8405-9.
1991: Peng Q; Farrants G W; Madslien K; Bommer J C; Moan J; Danielsen H E; Nesland J M
Subcellular localization, redistribution and photobleaching of sulfonated aluminum phthalocyanines in a human melanoma cell line.
International journal of cancer. Journal international du cancer 1991;49(2):290-5.
1991: Abeler V M; Kjørstad K E; Nesland J M
Undifferentiated carcinoma of the endometrium. A histopathologic and clinical study of 31 cases.
Cancer 1991;68(1):98-105.
1991: Berner A; Nesland J M
Endocrine profile in gastric carcinomas. An immunohistochemical study.
Histology and histopathology 1991;6(3):317-23.
1991: Jebsen P W; Hagmar B M; Nesland J M
Metaplastic breast carcinoma. A diagnostic problem in fine needle aspiration biopsy.
Acta cytologica 1991;35(4):396-402.
1991: Nesland J M; Ottestad L; Børresen A L; Tvedt K E; Holm R; Heikkilä R; Tveit K
The c-erbB-2 protein in primary and metastatic breast carcinomas.
Ultrastructural pathology 1991;15(3):281-9.
1991: Fosså S D; Nesland J M; Waehre H; Amellem O; Pettersen E O
DNA ploidy in the primary tumor from patients with nonseminomatous testicular germ cell tumors clinical stage I.
Cancer 1991;67(7):1874-7.
1991: Nesland J M; Ottestad L; Heikilla R; Holm R; Tveit K; Børresen A L
C-erbB-2 protein and neuroendocrine expression in breast carcinomas.
Anticancer research 1991;11(1):161-7.
1990: Peng Q; Moan J; Nesland J M; Rimington C
Aluminum phthalocyanines with asymmetrical lower sulfonation and with symmetrical higher sulfonation: a comparison of localizing and photosensitizing mechanism in human tumor LOX xenografts.
International journal of cancer. Journal international du cancer 1990;46(4):719-26.
1990: Børresen A L; Ottestad L; Gaustad A; Andersen T I; Heikkilä R; Jahnsen T; Tveit K M; Nesland J M
Amplification and protein over-expression of the neu/HER-2/c-erbB-2 protooncogene in human breast carcinomas: relationship to loss of gene sequences on chromosome 17, family history and prognosis.
British journal of cancer 1990;62(4):585-90.
1990: Peng Q; Nesland J M; Moan J; Evensen J F; Kongshaug M; Rimington C
Localization of fluorescent Photofrin II and aluminum phthalocyanine tetrasulfonate in transplanted human malignant tumor LOX and normal tissues of nude mice using highly light-sensitive video intensification microscopy.
International journal of cancer. Journal international du cancer 1990;45(5):972-9.
1990: Jacobsen A B; Nesland J M; Fosså S D; Pettersen E O
Human chorionic gonadotropin, neuron specific enolase and deoxyribonucleic acid flow cytometry in patients with high grade bladder carcinoma.
The Journal of urology 1990;143(4):706-9.
1990: Berner A; Børmer O; Marton P F; Nesland J M
Distribution of the carcinoembryonic antigen CEA in gastric lesions. Immunohistochemical testing of three novel monoclonal antibodies.
Histology and histopathology 1990;5(2):199-204.
1990: Kjønniksen I; Nesland J M; Pihl A; Fodstad O
Nude rat model for studying metastasis of human tumor cells to bone and bone marrow.
Journal of the National Cancer Institute 1990;82(5):408-12.
1990: Fosså S D; Nesland J M; Melvik J E; Jacobsen A B; Moe B
Prediction of objective response to recombinant interferon-alpha with or without vinblastine in metastatic renal cell carcinoma.
Acta oncologica (Stockholm, Sweden) 1990;29(3):303-6.
1989: Dasovic-Knezevic M; Børmer O; Holm R; Høie J; Sobrinho-Simões M; Nesland J M
Carcinoembryonic antigen in medullary thyroid carcinoma: an immunohistochemical study applying six novel monoclonal antibodies.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1989;2(6):610-7.
1989: Abeler V; Nesland J M
Alveolar soft-part sarcoma in the uterine cervix.
Archives of pathology & laboratory medicine 1989;113(10):1179-83.
1989: Ottestad L; Tveit K M; Hannisdal E; Skrede M; Nesland J M; Gundersen S; Pihl A
Colony forming ability of human breast carcinomas: lack of prognostic significance.
British journal of cancer 1989;60(2):216-9.
1989: Holm R; Nesland J M; Attramadal A; Halse J; Johannessen J V
Null cell adenomas of the pituitary gland. An immunohistochemical study.
The Journal of pathology 1989;158(3):213-7.
1989: Holm R; Nesland J M; Attramadal A; Reinli S; Johannessen J V
Mixed growth hormone- and prolactin cell adenomas of the pituitary gland. An immunoelectron microscopic study.
Journal of submicroscopic cytology and pathology 1989;21(2):339-50.
1989: Saeter G; Schwarze P E; Nesland J M; Seglen P O
Diploid nature of hepatocellular tumours developing from transplanted preneoplastic liver cells.
British journal of cancer 1989;59(2):198-205.
1989: Seglen P O; Skomedal H; Saeter G; Schwarze P E; Nesland J M
Neuroendocrine dysdifferentiation and bombesin production in carcinogen-induced hepatocellular rat tumours.
Carcinogenesis 1989;10(1):21-5.
1989: Holm R; Farrants G W; Nesland J M; Sobrinho-Simões M; Jørgensen O G; Johannessen J V
Ultrastructural and electron immunohistochemical features of medullary thyroid carcinoma.
Virchows Archiv. A, Pathological anatomy and histopathology 1989;414(5):375-84.
1988: Fodstad O; Kjønniksen I; Aamdal S; Nesland J M; Boyd M R; Pihl A
Extrapulmonary, tissue-specific metastasis formation in nude mice injected with FEMX-I human melanoma cells.
Cancer research 1988;48(15):4382-8.
1988: Ottestad L; Tveit K M; Høifødt H K; Nesland J M; Vaage S; Høie J; Lund E; Pihl A
Cultivation of human breast carcinoma in soft agar. Experience with 237 fresh tumour specimens.
British journal of cancer 1988;58(1):8-12.
1988: Ottestad L O; Tveit K M; Nesland J M; Dybsjord I; Børmer O; Høie J; Pihl A
An immunocytochemical method for assaying oestrogen receptors in breast cancers. A comparison with the steroid binding assay.
Histology and histopathology 1988;3(3):269-74.
1988: Saeter G; Schwarze P E; Nesland J M; Juul N; Pettersen E O; Seglen P O
The polyploidizing growth pattern of normal rat liver is replaced by divisional, diploid growth in hepatocellular nodules and carcinomas.
Carcinogenesis 1988;9(6):939-45.
1988: Holm R; Nesland J M; Attramadal A; Johannessen J V
Double-staining methods at the ultrastructural level applying colloidal gold conjugates.
Ultrastructural pathology 1988;12(3):279-90.
1988: Nesland J M; Holm R; Johannessen J V; Gould V E
Neuroendocrine differentiation in breast lesions.
Pathology, research and practice 1988;183(2):214-21.
1988: Saeter G; Schwarze P E; Nesland J M; Seglen P O
2-Acetylaminofluorene promotion of liver carcinogenesis by a non-cytotoxic mechanism.
Carcinogenesis 1988;9(4):581-7.
1988: Fodstad O; Aamdal S; McMenamin M; Nesland J M; Pihl A
A new experimental metastasis model in athymic nude mice, the human malignant melanoma LOX.
International journal of cancer. Journal international du cancer 1988;41(3):442-9.
1988: Erikstein B; Nesland J M; Ottestad L; Lund E; Johannessen J V
Neuron specific enolase-positive breast carcinomas.
Histology and histopathology 1988;3(1):97-102.
1988: Nesland J M; Holm R; Ottestad L; Karlsen K O; Johannessen J V
Neuroendocrine activity in metastatic breast carcinomas.
APMIS. Supplementum 1988;2():204-14.
1987: Lunde S; Nesland J M; Holm R; Johannessen J V
Breast carcinomas with protein S-100 immunoreactivity. An immunocytochemical and ultrastructural study.
Pathology, research and practice 1987;182(5):627-31.
1987: Nesland J M; Lunde S; Holm R; Johannessen J V
Electron microscopy and immunostaining of the normal breast and its benign lesions. A search for neuroendocrine cells.
Histology and histopathology 1987;2(1):73-7.
1987: Lunde S; Nesland J M; Holm R; Johannessen J V
A urinary bladder tumor in a 65-year-old man.
Ultrastructural pathology 1987;11(1):79-82.
1987: Saeter G; Schwarze P E; Nesland J M; Seglen P O
Transplantation of preneoplastic rat hepatocytes by intraportal injection.
Toxicologic pathology 1987;15(1):78-81.
1987: Nesland J M; Holm R; Lunde S; Johannessen J V
Diagnostic problems in breast pathology: the benefit of ultrastructural and immunocytochemical analysis.
Ultrastructural pathology 1987;11(2-3):293-311.
1986: Pettersen E O; Schwarze P E; Dornish J M; Nesland J M
Antitumour effect of benzylidene-glucose (BG) in rats with chemically induced hepatocellular carcinoma.
Anticancer research 1986;6(2):147-52.
1986: Lunde S; Nesland J M; Holm R; Johannessen J V
Primary malignant fibrous histiocytoma of the breast.
Histology and histopathology 1986;1(1):27-32.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Jahn Nesland

Research Profile (preview)

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Genes & Molecular Sequences

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Jahn Nesland (preview)

All Publications